| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Mimiviridae | 13 | 2018 | 27 | 5.11 | Why? |
| Giant Viruses | 10 | 2019 | 27 | 5.04 | Why? |
| Acanthamoeba | 6 | 2018 | 36 | 1.98 | Why? |
| Acanthamoeba castellanii | 5 | 2018 | 39 | 1.89 | Why? |
| Virophages | 4 | 2019 | 9 | 1.67 | Why? |
| Amoeba | 5 | 2018 | 22 | 1.59 | Why? |
| RNA, Ribosomal, 16S | 7 | 2018 | 793 | 1.21 | Why? |
| Protein Biosynthesis | 3 | 2018 | 653 | 1.13 | Why? |
| Metagenomics | 5 | 2020 | 823 | 1.05 | Why? |
| Interspersed Repetitive Sequences | 2 | 2019 | 29 | 0.95 | Why? |
| DNA Viruses | 3 | 2017 | 184 | 0.88 | Why? |
| Judaism | 1 | 2020 | 45 | 0.82 | Why? |
| Peptide Initiation Factors | 1 | 2018 | 29 | 0.74 | Why? |
| Airports | 1 | 2021 | 284 | 0.73 | Why? |
| DEAD-box RNA Helicases | 1 | 2018 | 99 | 0.69 | Why? |
| Chlamydiales | 1 | 2017 | 21 | 0.67 | Why? |
| RNA, Transfer | 1 | 2017 | 66 | 0.67 | Why? |
| DNA Virus Infections | 1 | 2018 | 88 | 0.67 | Why? |
| Bacterial Typing Techniques | 3 | 2017 | 273 | 0.66 | Why? |
| Bacteria, Anaerobic | 2 | 2018 | 20 | 0.65 | Why? |
| Genome, Bacterial | 2 | 2018 | 446 | 0.65 | Why? |
| Virology | 3 | 2019 | 489 | 0.65 | Why? |
| DNA, Viral | 11 | 2018 | 2521 | 0.64 | Why? |
| Bacteria | 3 | 2018 | 1897 | 0.64 | Why? |
| Molecular Sequence Annotation | 1 | 2018 | 478 | 0.62 | Why? |
| Evolution, Molecular | 4 | 2018 | 3691 | 0.61 | Why? |
| Metagenome | 1 | 2018 | 268 | 0.61 | Why? |
| Urine | 1 | 2018 | 469 | 0.57 | Why? |
| Diabetic Foot | 1 | 2018 | 317 | 0.53 | Why? |
| Microbiota | 3 | 2018 | 1240 | 0.52 | Why? |
| Viral Interference | 1 | 2013 | 33 | 0.52 | Why? |
| Virion | 3 | 2018 | 1444 | 0.51 | Why? |
| Ships | 1 | 2021 | 1046 | 0.49 | Why? |
| Bartonella henselae | 3 | 2018 | 28 | 0.47 | Why? |
| Azithromycin | 8 | 2021 | 3943 | 0.46 | Why? |
| Image Processing, Computer-Assisted | 1 | 2020 | 1383 | 0.45 | Why? |
| Genome, Viral | 11 | 2020 | 13157 | 0.44 | Why? |
| Phylogeny | 11 | 2021 | 13341 | 0.44 | Why? |
| Genomics | 4 | 2019 | 3118 | 0.43 | Why? |
| Cat-Scratch Disease | 2 | 2017 | 17 | 0.42 | Why? |
| Genes, Bacterial | 1 | 2011 | 207 | 0.41 | Why? |
| France | 15 | 2021 | 12074 | 0.40 | Why? |
| Flow Cytometry | 2 | 2021 | 2393 | 0.38 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2017 | 449 | 0.37 | Why? |
| Polymerase Chain Reaction | 6 | 2021 | 6740 | 0.37 | Why? |
| Lymphadenitis | 2 | 2018 | 53 | 0.34 | Why? |
| Viral Load | 7 | 2021 | 15850 | 0.34 | Why? |
| Microscopy, Electron | 3 | 2020 | 830 | 0.33 | Why? |
| RNA, Viral | 7 | 2021 | 32276 | 0.32 | Why? |
| Q Fever | 2 | 1998 | 130 | 0.31 | Why? |
| Hydroxychloroquine | 8 | 2021 | 12447 | 0.31 | Why? |
| RNA, Bacterial | 3 | 2017 | 116 | 0.30 | Why? |
| Viral Proteins | 3 | 2018 | 7370 | 0.29 | Why? |
| Microscopy, Electron, Transmission | 2 | 2017 | 605 | 0.28 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.28 | Why? |
| Virus Replication | 7 | 2021 | 14331 | 0.28 | Why? |
| Host Specificity | 2 | 2021 | 926 | 0.28 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.28 | Why? |
| Endocarditis, Bacterial | 2 | 2020 | 344 | 0.27 | Why? |
| Gastroscopes | 1 | 2003 | 8 | 0.27 | Why? |
| Actinomycetales | 1 | 2003 | 9 | 0.27 | Why? |
| Sequence Analysis, DNA | 5 | 2018 | 2830 | 0.26 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.26 | Why? |
| Glutaral | 1 | 2003 | 22 | 0.26 | Why? |
| Host-Pathogen Interactions | 4 | 2019 | 11041 | 0.26 | Why? |
| Promoter Regions, Genetic | 2 | 2017 | 823 | 0.25 | Why? |
| Angiomatosis, Bacillary | 1 | 2002 | 3 | 0.25 | Why? |
| Whipple Disease | 1 | 2003 | 38 | 0.25 | Why? |
| Peracetic Acid | 1 | 2003 | 68 | 0.25 | Why? |
| Genes, Viral | 2 | 2018 | 1428 | 0.23 | Why? |
| DNA, Bacterial | 4 | 2021 | 835 | 0.23 | Why? |
| In Situ Hybridization, Fluorescence | 3 | 2017 | 207 | 0.22 | Why? |
| Transplant Recipients | 1 | 2018 | 4982 | 0.22 | Why? |
| Mefloquine | 1 | 2020 | 39 | 0.22 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2021 | 13720 | 0.22 | Why? |
| Amodiaquine | 1 | 2020 | 57 | 0.21 | Why? |
| Automation, Laboratory | 2 | 2021 | 536 | 0.21 | Why? |
| Lymph Nodes | 2 | 2018 | 1060 | 0.21 | Why? |
| Vero Cells | 7 | 2020 | 14117 | 0.21 | Why? |
| Doxycycline | 2 | 2020 | 307 | 0.21 | Why? |
| Coculture Techniques | 2 | 2018 | 258 | 0.20 | Why? |
| Antimalarials | 3 | 2021 | 2505 | 0.20 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2020 | 393 | 0.19 | Why? |
| Betacoronavirus | 16 | 2020 | 204454 | 0.19 | Why? |
| Angiotensin I | 1 | 2021 | 200 | 0.19 | Why? |
| Life Cycle Stages | 1 | 2019 | 162 | 0.19 | Why? |
| Bacteriological Techniques | 2 | 2018 | 239 | 0.19 | Why? |
| Alphaproteobacteria | 1 | 2018 | 6 | 0.19 | Why? |
| Biguanides | 1 | 2018 | 7 | 0.19 | Why? |
| DNA, Intergenic | 1 | 2017 | 7 | 0.18 | Why? |
| Blotting, Western | 1 | 2021 | 863 | 0.18 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2021 | 635 | 0.18 | Why? |
| Acanthamoeba Keratitis | 1 | 2018 | 15 | 0.18 | Why? |
| Methylene Blue | 1 | 2020 | 175 | 0.18 | Why? |
| Virus Uncoating | 1 | 2017 | 10 | 0.18 | Why? |
| Enterobacteriaceae | 2 | 2021 | 395 | 0.18 | Why? |
| Artemisinins | 1 | 2020 | 238 | 0.18 | Why? |
| Synteny | 1 | 2017 | 38 | 0.18 | Why? |
| Lobosea | 1 | 2017 | 2 | 0.18 | Why? |
| Seawater | 1 | 2018 | 60 | 0.18 | Why? |
| RNA, Ribosomal, 23S | 1 | 2017 | 25 | 0.17 | Why? |
| Lakes | 1 | 2018 | 83 | 0.17 | Why? |
| Oceans and Seas | 1 | 2018 | 73 | 0.17 | Why? |
| Nucleotide Motifs | 1 | 2017 | 58 | 0.17 | Why? |
| Amino Acyl-tRNA Synthetases | 1 | 2017 | 14 | 0.17 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.17 | Why? |
| Base Composition | 1 | 2017 | 203 | 0.16 | Why? |
| Microscopy | 1 | 2020 | 414 | 0.16 | Why? |
| Clostridium | 1 | 2016 | 33 | 0.16 | Why? |
| Enterovirus | 1 | 2020 | 402 | 0.16 | Why? |
| Cell Culture Techniques | 1 | 2021 | 704 | 0.16 | Why? |
| Coxiella burnetii | 1 | 2017 | 120 | 0.16 | Why? |
| Animals | 13 | 2021 | 78931 | 0.16 | Why? |
| Virus Shedding | 3 | 2021 | 5834 | 0.15 | Why? |
| Nasopharynx | 8 | 2021 | 10224 | 0.15 | Why? |
| Water Microbiology | 1 | 2018 | 248 | 0.15 | Why? |
| Cytoplasm | 1 | 2017 | 304 | 0.15 | Why? |
| Antiviral Agents | 7 | 2021 | 41703 | 0.15 | Why? |
| Humans | 51 | 2021 | 930598 | 0.15 | Why? |
| Angiotensin II | 1 | 2021 | 601 | 0.15 | Why? |
| Capsid Proteins | 1 | 2018 | 365 | 0.14 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.14 | Why? |
| Endocarditis | 1 | 2020 | 368 | 0.14 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.14 | Why? |
| Amebiasis | 1 | 2014 | 20 | 0.14 | Why? |
| Cell Nucleus | 1 | 2017 | 399 | 0.14 | Why? |
| Prosthesis-Related Infections | 1 | 2018 | 302 | 0.14 | Why? |
| Wound Healing | 1 | 2018 | 424 | 0.13 | Why? |
| Air Travel | 1 | 2021 | 585 | 0.13 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.13 | Why? |
| Specimen Handling | 3 | 2020 | 6190 | 0.13 | Why? |
| Equipment Contamination | 1 | 2003 | 1308 | 0.13 | Why? |
| Biological Evolution | 1 | 2019 | 641 | 0.13 | Why? |
| Zinc | 1 | 2021 | 817 | 0.13 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.12 | Why? |
| DNA Transposable Elements | 1 | 2012 | 91 | 0.12 | Why? |
| Disinfectants | 1 | 2003 | 1077 | 0.12 | Why? |
| Propionibacterium | 1 | 2011 | 5 | 0.12 | Why? |
| Genes, rRNA | 1 | 2011 | 10 | 0.12 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.12 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.12 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.12 | Why? |
| Monocytes | 2 | 2021 | 2978 | 0.12 | Why? |
| Databases, Genetic | 1 | 2018 | 1127 | 0.11 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.11 | Why? |
| Aged, 80 and over | 12 | 2021 | 88759 | 0.11 | Why? |
| Root Canal Irrigants | 1 | 2010 | 6 | 0.11 | Why? |
| Root Canal Preparation | 1 | 2010 | 5 | 0.11 | Why? |
| Proteome | 2 | 2018 | 1812 | 0.11 | Why? |
| Dental Pulp Cavity | 1 | 2010 | 16 | 0.11 | Why? |
| Adult | 21 | 2021 | 244371 | 0.11 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.11 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.10 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2020 | 1234 | 0.10 | Why? |
| Male | 26 | 2021 | 367725 | 0.10 | Why? |
| Bacteriophages | 1 | 2012 | 268 | 0.10 | Why? |
| Sodium Hypochlorite | 1 | 2010 | 110 | 0.10 | Why? |
| Drug Therapy, Combination | 5 | 2021 | 7268 | 0.10 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.10 | Why? |
| Macrophages | 1 | 2021 | 2784 | 0.10 | Why? |
| Adolescent | 13 | 2021 | 86841 | 0.10 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| Water | 1 | 2014 | 765 | 0.09 | Why? |
| Aged | 18 | 2021 | 215776 | 0.09 | Why? |
| Cities | 1 | 2021 | 4937 | 0.09 | Why? |
| Antihypertensive Agents | 1 | 2021 | 1962 | 0.09 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.09 | Why? |
| Dietary Supplements | 1 | 2021 | 2251 | 0.09 | Why? |
| Middle Aged | 20 | 2021 | 270681 | 0.09 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.09 | Why? |
| Influenza A virus | 1 | 2020 | 2234 | 0.09 | Why? |
| Female | 24 | 2021 | 380317 | 0.09 | Why? |
| High-Throughput Screening Assays | 1 | 2017 | 1783 | 0.09 | Why? |
| Environment | 1 | 2014 | 769 | 0.08 | Why? |
| Child, Preschool | 6 | 2020 | 36283 | 0.08 | Why? |
| Infant | 5 | 2020 | 30274 | 0.08 | Why? |
| Viruses | 1 | 2020 | 2238 | 0.08 | Why? |
| Drug Synergism | 2 | 2021 | 833 | 0.08 | Why? |
| Young Adult | 11 | 2021 | 93724 | 0.08 | Why? |
| Waste Water | 1 | 2018 | 2185 | 0.08 | Why? |
| Species Specificity | 1 | 2011 | 1356 | 0.08 | Why? |
| Guinea Pigs | 2 | 1998 | 420 | 0.08 | Why? |
| Base Sequence | 3 | 2017 | 3581 | 0.08 | Why? |
| Antibodies, Bacterial | 2 | 2002 | 510 | 0.08 | Why? |
| Research | 1 | 2019 | 2115 | 0.08 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.08 | Why? |
| Computational Biology | 2 | 2018 | 4514 | 0.08 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.07 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 2309 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.07 | Why? |
| Brazil | 2 | 2018 | 12582 | 0.06 | Why? |
| India | 1 | 2021 | 11875 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.06 | Why? |
| DNA, Ribosomal | 1 | 2002 | 112 | 0.06 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.06 | Why? |
| Molecular Sequence Data | 2 | 2012 | 3198 | 0.06 | Why? |
| Serotyping | 1 | 2002 | 154 | 0.06 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 238 | 0.06 | Why? |
| Anti-Bacterial Agents | 3 | 2021 | 10083 | 0.06 | Why? |
| Micrococcaceae | 1 | 2021 | 72 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2018 | 4239 | 0.06 | Why? |
| Siphonaptera | 1 | 2001 | 21 | 0.06 | Why? |
| Sputum | 2 | 2020 | 1720 | 0.06 | Why? |
| Moraxella | 1 | 2020 | 9 | 0.05 | Why? |
| Drug Combinations | 2 | 2021 | 3852 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Child | 5 | 2020 | 70012 | 0.05 | Why? |
| Rickettsia | 1 | 2001 | 101 | 0.05 | Why? |
| Microbial Sensitivity Tests | 2 | 2020 | 2886 | 0.05 | Why? |
| Genotype | 2 | 2021 | 4697 | 0.05 | Why? |
| Genomic Islands | 1 | 2018 | 26 | 0.05 | Why? |
| Joint Prosthesis | 1 | 2018 | 20 | 0.05 | Why? |
| Francisella tularensis | 1 | 2018 | 28 | 0.05 | Why? |
| HLA-DR Antigens | 1 | 2021 | 563 | 0.05 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.05 | Why? |
| Pilot Projects | 2 | 2021 | 5182 | 0.05 | Why? |
| Virus Internalization | 1 | 2017 | 7921 | 0.05 | Why? |
| Gene Transfer, Horizontal | 1 | 2018 | 64 | 0.05 | Why? |
| Lipopolysaccharide Receptors | 1 | 2021 | 357 | 0.05 | Why? |
| Fluorescent Antibody Technique | 1 | 2021 | 835 | 0.05 | Why? |
| Corynebacterium Infections | 1 | 2018 | 26 | 0.04 | Why? |
| Streptococcus | 1 | 2018 | 76 | 0.04 | Why? |
| Corynebacterium | 1 | 2018 | 47 | 0.04 | Why? |
| Colony Count, Microbial | 1 | 2018 | 177 | 0.04 | Why? |
| Microbiological Techniques | 1 | 2020 | 232 | 0.04 | Why? |
| Staphylococcus | 1 | 2018 | 77 | 0.04 | Why? |
| Blood Culture | 1 | 2020 | 308 | 0.04 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.04 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3633 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2020 | 1027 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.04 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.04 | Why? |
| Keratitis | 1 | 2018 | 102 | 0.04 | Why? |
| Benzamidines | 1 | 2018 | 206 | 0.04 | Why? |
| Mycobacterium | 1 | 2018 | 143 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Cat Diseases | 1 | 2002 | 539 | 0.04 | Why? |
| Malaria, Falciparum | 1 | 2020 | 377 | 0.04 | Why? |
| Culture Media | 1 | 2018 | 366 | 0.04 | Why? |
| Chloroquine | 2 | 2021 | 3152 | 0.04 | Why? |
| Phagocytosis | 1 | 2017 | 409 | 0.04 | Why? |
| Cats | 1 | 2002 | 1890 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.04 | Why? |
| Equipment Reuse | 1 | 2003 | 985 | 0.04 | Why? |
| Cell Survival | 1 | 2020 | 1581 | 0.04 | Why? |
| Rhinovirus | 1 | 2020 | 979 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| Nigeria | 1 | 2021 | 2292 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Bacterial Proteins | 1 | 2002 | 1318 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.03 | Why? |
| Gene Expression Regulation, Viral | 1 | 2018 | 925 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.03 | Why? |
| Drug Repositioning | 2 | 2021 | 5683 | 0.03 | Why? |
| Mice, Inbred BALB C | 1 | 2002 | 5814 | 0.03 | Why? |
| Bacteremia | 1 | 2002 | 1372 | 0.03 | Why? |
| Sonication | 1 | 2010 | 18 | 0.03 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.03 | Why? |
| Ultrasonics | 1 | 2010 | 41 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Malaria | 1 | 2020 | 1097 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Turkey | 1 | 2021 | 3937 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Vibration | 1 | 2010 | 68 | 0.02 | Why? |
| Syringes | 1 | 2010 | 70 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.02 | Why? |
| Enterococcus faecalis | 1 | 2010 | 126 | 0.02 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Therapeutic Irrigation | 1 | 2010 | 167 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.02 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.02 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Single-Cell Analysis | 1 | 2018 | 2450 | 0.02 | Why? |
| CRISPR-Cas Systems | 1 | 2016 | 1397 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Chi-Square Distribution | 1 | 2010 | 961 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2016 | 2585 | 0.02 | Why? |
| Acute Disease | 1 | 1997 | 6029 | 0.02 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.02 | Why? |
| Antibodies, Monoclonal | 1 | 2002 | 8041 | 0.02 | Why? |
| Liver | 1 | 1997 | 4007 | 0.02 | Why? |
| Mice | 1 | 2002 | 21357 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
| Myocarditis | 1 | 1997 | 2731 | 0.01 | Why? |
| Travel | 1 | 2020 | 7220 | 0.01 | Why? |
| Disease Models, Animal | 1 | 1998 | 10998 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2003 | 9044 | 0.01 | Why? |
| Models, Biological | 1 | 2016 | 4907 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Hospitals | 1 | 2014 | 11793 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Lung | 1 | 1997 | 31049 | 0.01 | Why? |